Gaipov A 2
51. Assessing the impact of COVID-19 on renal health in recovered patients: a multi-center longitudinal study
52. COVID-19 Infection in patients with Chronic Kidney Disease: Prognosis and Pharmacological Management
53. Mortality of cases with chronic kidney disease and its risk factors admitted to hospital with COVID-19 in Almaty city, Kazakhstan
54. Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021
55. Understanding the Role of Sex Hormones in Cardiovascular Kidney Metabolic Syndrome: Toward Personalized Therapeutic Approaches
56. Review of the research databases on population-based Registries of Unified electronic Healthcare system of Kazakhstan (UNEHS): Possibilities and limitations for epidemiological research and Real-World Evidence
57. The global, regional, and national burden attributable to low bone mineral density, 1990–2020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021
58. Differences in cardiac mechanics assessed by left ventricular hemodynamic forces in athletes and patients with hypertension
59. Benchmarking ChatGPT and Other Large Language Models for Personalized Stage-Specific Dietary Recommendations in Chronic Kidney Disease
60. Prescription Patterns of Antiseizure Medication in Adult Patients with Epilepsy in Kazakhstan (2021–2023)
61. Modeling tuberculosis transmission dynamics in Kazakhstan using SARIMA and SIR models
62. An update review of post-transplant diabetes mellitus: Concept, risk factors, clinical implications and management
63. Effect of tirzepatide on blood pressure and lipids: A meta-analysis of randomized controlled trials
64. The nonadherence to prescriptions among type 2 diabetes patients, and its determining factors
65. Mechano-Chemistry across Phase Transitions in Heated Albumin Protein Solutions
66. Late diagnosis of CKD and associated survival after initiation of renal replacement therapy in Kazakhstan: analysis of nationwide electronic healthcare registry 2014–2019
67. In-situ, real-time monitoring of thermo-mechanical properties of biological tissues undergoing laser heating and ablation
68. Thermo-Visco-Elastometry of RF-Wave-Heated and Ablated Flesh Tissues Containing Au Nanoparticles
69. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
70. Candidate protein biomarkers in chronic kidney disease: a proteomics study
71. Tubular toxicity of proteinuria and the progression of chronic kidney disease
72. Urinary Proteomic Shifts over Time and Their Associations with eGFR Decline in Chronic Kidney Disease
73. Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023
74. Comparative Analysis of Regional Mortality Rates and Causes in the Turkistan and Other Regions of Kazakhstan: Data from Unified National Electronic Healthcare System 2018-2023
75. Forecasting the future burden of major diseases in Kazakhstan using global burden of disease and time series models (ARIMA, Prophet, LSTM), 2019-2032
76. Prevalence, incidence, and mortality rates of breast cancer in Kazakhstan: data from the Unified National Electronic Health System, 2014–2019
77. Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019
78. Dynamics of hospital admissions and all-cause mortality of HIV infected patients in Kazakhstan: data from unified nationwide electronic healthcare system 2014–2019
79. Epidemiology of pediatric hematological malignancies in Kazakhstan: Data from Unified National Electronic Healthcare System 2014–2021
80. Prevalence of HIV in Kazakhstan 2010–2020 and Its Forecasting for the Next 10 Years
81. Awareness of chronic kidney disease and its risk factors in the former Soviet Union countries
82. Health-related quality of life in chronic kidney disease patients in low- and lower-middle income countries: a systematic review and meta-analysis
83. Quality of life in patients with chronic kidney disease in low- and middle-income countries: protocol for a systematic review and meta-analysis
84. Impact of the COVID-19 pandemic on TB epidemiology
85. Seroprevalence and risk factors for hepatitis B and hepatitis C in three large regions of Kazakhstan
86. Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
87. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
88. Assessing the impact of screening, early identification and intervention programmes for chronic kidney disease: Protocol for a scoping review
89. Early Identification of CKD—A Scoping Review of the Global Populations
90. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
91. Overweight effects on metabolic rate, time perception, diseases, aging, and lifespan: A systematic review with meta-regression analysis
92. Patients receiving hemodialysis do not lose SARS-CoV-2 antibodies more rapidly than non-renal controls: a prospective cohort study
93. Cannabis Use and Risk of Acute Kidney Injury in Patients with Advanced Chronic Kidney Disease Transitioning to Dialysis
94. Epidemiology, detection, diagnosis and treatment of TB in children in Kazakhstan
95. Capacity for the management of kidney failure in the International Society of Nephrology Newly Independent States and Russia region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)
96. Mortality predictors of hospitalized patients with COVID-19: Retrospective cohort study from Nur-Sultan, Kazakhstan
97. Survival disparities and predictors in gastric cancer: a population-based study from Kazakhstan (2012–2023)
98. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage The Global Burden of Disease Study 2021
99. Predictors of All-cause Mortality among Hospitalized HIV Patients in Kazakhstan: a Retrospective Study
100. Epidemiology of spontaneous pregnancy loss in Kazakhstan: A national population-based cohort analysis during 2014–2019 using the national electronic healthcare system
1 2 3